Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

Subject: Multiple Sclerosis - PUBLISHED VIA Clinical Therapeutics

Author(s):
Rog DJ, Nurmikko TJ, Young CA

Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom. [email protected]

View Source >> (Price: $36)

Related Studies:

View all medical studies

Popular Articles

www.photolifeway.com

www.zaraz.org.ua

ссылка